The National Health Research Institutes (NHRI) yesterday said its researchers had engineered a novel vascular construct of a stem cell-laden 3D-printed scaffold that can enhance tissue revascularization.
As restoring or replacing a malfunctioning human organ is very difficult and waiting for a suitable organ for a transplant can take a long time, transplantable engineered tissue is highly sought after, but its development has been hampered by the lack of a vascular network within the engineered tissue.
The research team manufactured a novel 3D architecture scaffold with poly(glycerol sebacate) acrylate (PGSA), serving as a functional and transplantable vascular construct, which provides an innovative alternative therapeutic strategy for vascular tissue engineering, and could possibly be used to treat ischemic disease and for organ transplants.
Photo: Wu Liang-yi, Taipei Times
The research team is led by NHRI Institute of Cellular and System Medicine director Yet Shaw-fang (林秀芳) and Jane Wang (王潔), an associate professor at National Tsing Hua University’s Department of Chemistry.
To repair or regenerate ischemic tissues, revascularization is essential to support the delivery of oxygen and nutrients to the cells and to clear waste products, Jiang Wei-cheng (蔣偉程), a postdoctoral fellow at the NHRI Institute of Cellular and System Medicine, said yesterday.
One of the more recent strategies is “prevascularization,” or forming microvascular networks within the tissue construct before implantation, Jiang said.
However, a major challenge during development is insufficient cell supply in the initial stage prior to implantation, he said, adding that another challenge is selecting the biomaterial and the architecture scaffold for the development of an efficient and effective vascular construct.
Jiang said the team took a regenerative engineering approach by taking stem cells and utilizing a digital light processing system to manufacture a recently designed novel 3D-printed architecture scaffold with PGSA, to be used for the generation of novel vascular constructs.
Transplantation of the vascular construct in wounded mice resulted in the formation of a new vascular network that integrated into the existing vasculature of the host tissue, leading to revascularization and enhanced blood perfusion at the implant site, Lin said.
The technology for engineering the vascular construct could be further developed to help treat diseases, such as peripheral arterial disease in people with diabetes or another ischemic disease, she said, adding that it could also be used for organ transplants, drug testing, or in vitro tissue or organ engineering.
The team’s study was published by the journal Biofabrication in July last year, the NHRI said.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
Carrefour Taiwan is to begin using a new name from the start of July, but it cannot divulge the name until then, the chairman of the supermarket chain's parent company said today. President Chain Store Co chairman Lo Chih-hsien (羅智先) was asked by reporters after a shareholders' meeting to confirm whether the company has settled on a new name for the supermarket brand. In March, the government-registered name of two Carrefour Taiwan branches was quietly changed to "Le Chia Kang" (樂家康) in Chinese, raising speculation that has been selected as the name. Lo said that because of local regulations and contractual obligations, the
The Philippines would likely be involved in any conflict over Taiwan due to its proximity to the democracy claimed by China, President Ferdinand Marcos Jr said, reiterating a stance that risks angering Beijing. “In the Philippines, we do not have a choice because Taiwan is so close to the Philippines and we have almost 200,000 Filipino nationals living and working in Taiwan,” Marcos said in an interview with Japanese media in Manila on Monday. The Philippine leader’s comments come ahead of a state visit to Japan next week, where he is to meet with Japanese Prime Minister Sanae Takaichi to discuss security
RSS